Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-08

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cetirizine hydrochloride submitted by Rising Pharma Holdings, Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)